[go: up one dir, main page]

PL377578A1 - Zastosowanie konglutyny łubinu w leczeniu cukrzycy typu II - Google Patents

Zastosowanie konglutyny łubinu w leczeniu cukrzycy typu II

Info

Publication number
PL377578A1
PL377578A1 PL377578A PL37757804A PL377578A1 PL 377578 A1 PL377578 A1 PL 377578A1 PL 377578 A PL377578 A PL 377578A PL 37757804 A PL37757804 A PL 37757804A PL 377578 A1 PL377578 A1 PL 377578A1
Authority
PL
Poland
Prior art keywords
lupin conglutin
diabetes
treatment
lupin
type
Prior art date
Application number
PL377578A
Other languages
English (en)
Other versions
PL214193B1 (pl
Inventor
Paolo Morazzoni
Marcello Duranti
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of PL377578A1 publication Critical patent/PL377578A1/pl
Publication of PL214193B1 publication Critical patent/PL214193B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
PL377578A 2003-02-11 2004-02-06 Zastosowanie konglutyny gamma lubinu do wytwarzania leku do leczenia cukrzycy typu II, jako czynnika terapeutycznego i hipoglikemizujacego oraz farmaceutyczne lub zywieniowe kompozycje zawierajace konglutyne gamma lubinu PL214193B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000237A ITMI20030237A1 (it) 2003-02-11 2003-02-11 Uso della conglutina di lupino per il trattamento del

Publications (2)

Publication Number Publication Date
PL377578A1 true PL377578A1 (pl) 2006-02-06
PL214193B1 PL214193B1 (pl) 2013-06-28

Family

ID=32866063

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377578A PL214193B1 (pl) 2003-02-11 2004-02-06 Zastosowanie konglutyny gamma lubinu do wytwarzania leku do leczenia cukrzycy typu II, jako czynnika terapeutycznego i hipoglikemizujacego oraz farmaceutyczne lub zywieniowe kompozycje zawierajace konglutyne gamma lubinu

Country Status (20)

Country Link
US (1) US7323441B2 (pl)
EP (1) EP1605957B1 (pl)
JP (2) JP2006517212A (pl)
KR (2) KR101084434B1 (pl)
CN (1) CN1747739B (pl)
AT (1) ATE391510T1 (pl)
AU (1) AU2004212297B2 (pl)
CA (1) CA2515607C (pl)
CY (1) CY1108138T1 (pl)
DE (1) DE602004012984T2 (pl)
DK (1) DK1605957T3 (pl)
ES (1) ES2303937T3 (pl)
IL (1) IL170200A (pl)
IT (1) ITMI20030237A1 (pl)
NO (1) NO333224B1 (pl)
PL (1) PL214193B1 (pl)
PT (1) PT1605957E (pl)
RU (1) RU2339393C2 (pl)
SI (1) SI1605957T1 (pl)
WO (1) WO2004071521A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030237A1 (it) * 2003-02-11 2004-08-12 Indena Spa Uso della conglutina di lupino per il trattamento del
WO2009144278A2 (en) 2008-05-30 2009-12-03 Fondazione Centro San Raffaele Del Monte Tabor USES OF CONGLUTIN-γ
EP2411137B1 (en) 2009-03-27 2016-09-07 Bend Research, Inc. Spray-drying process
PT2611529T (pt) 2010-09-03 2019-05-09 Bend Res Inc Método de secagem por pulverização
US9084944B2 (en) 2010-09-03 2015-07-21 Bend Research, Inc. Spray-drying apparatus and methods of using the same
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
SG189379A1 (en) 2010-10-12 2013-05-31 Consumo Em Verde Biotecnologia Das Plantas S A Antimicrobial protein
CN106714579B (zh) * 2014-06-30 2021-07-27 普罗卢平有限公司 含有羽扇豆蛋白质的乳剂
US11364203B2 (en) 2014-10-31 2022-06-21 Bend Reserch, Inc. Process for forming active domains dispersed in a matrix

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU66892A (sh) * 1991-08-20 1995-10-24 Hoechst Ag. Fosfoinositolglikan - peptid sa delovanjem kao insulin
JPH08127538A (ja) * 1994-10-31 1996-05-21 Masakiyo Takahashi 糖尿病治療薬
JPH0967252A (ja) * 1995-09-05 1997-03-11 Zenkoku Royal Jelly Kosei Torihiki Kiyougikai ローヤルゼリーに含まれるトランス−１０−ヒドロキシ−デセン酸を有効成分とするアンジオテンシン転換酵素阻害剤及びインスリン様作用剤
ITMI20030237A1 (it) * 2003-02-11 2004-08-12 Indena Spa Uso della conglutina di lupino per il trattamento del

Also Published As

Publication number Publication date
JP2006517212A (ja) 2006-07-20
ES2303937T3 (es) 2008-09-01
DK1605957T3 (da) 2008-08-11
HK1085927A1 (en) 2006-09-08
DE602004012984D1 (de) 2008-05-21
EP1605957B1 (en) 2008-04-09
CN1747739A (zh) 2006-03-15
SI1605957T1 (sl) 2008-08-31
EP1605957A1 (en) 2005-12-21
DE602004012984T2 (de) 2009-06-04
JP2012153715A (ja) 2012-08-16
PL214193B1 (pl) 2013-06-28
ATE391510T1 (de) 2008-04-15
NO333224B1 (no) 2013-04-15
US20060142185A1 (en) 2006-06-29
KR20110033312A (ko) 2011-03-30
JP5504301B2 (ja) 2014-05-28
US7323441B2 (en) 2008-01-29
AU2004212297B2 (en) 2009-09-10
ITMI20030237A1 (it) 2004-08-12
KR20050106415A (ko) 2005-11-09
WO2004071521A1 (en) 2004-08-26
CY1108138T1 (el) 2014-02-12
AU2004212297A1 (en) 2004-08-26
CN1747739B (zh) 2013-04-17
PT1605957E (pt) 2008-06-27
KR101084434B1 (ko) 2011-11-21
IL170200A (en) 2010-05-31
NO20053788L (no) 2005-11-11
CA2515607A1 (en) 2004-08-26
RU2005125411A (ru) 2006-01-27
RU2339393C2 (ru) 2008-11-27
NO20053788D0 (no) 2005-08-10
CA2515607C (en) 2013-10-15

Similar Documents

Publication Publication Date Title
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
HK1049431A1 (zh) 用於增加肌肉塊和力量的食物補充方法
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
ZA200501559B (en) Probiotics for gut neuromuscular functions
WO2004052295A3 (en) Compositions and methods for nutrition supplementation
DE60032781D1 (de) Nahrungsmittelzusatz zur zunahme der fettarmen körpermasse und kraft
HUP0204574A3 (en) Propionic acid derivatives and their use in the treatment of diabetes and obesity, pharmaceutical compositions containing them and their preparation
MXPA02011476A (es) Fuente de triptofano de plantas y usos para el mismo.
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
IL172898A0 (en) Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus
WO2005123108A3 (en) Advanced vitamins and protein based nutritional supplements
TW200513197A (en) Amino acid supplementation for a healthy microbiota ecosystem
WO2001091769A3 (en) Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
BRPI0410761A (pt) uso de leucina, e, composição para administração entérica a pacientes
JP2017057147A (ja) ニンニク等、低塩分濃度の味噌、及びビタミンｂ１を含有する組成物
WO2002089741A3 (en) Compositions and methods for enhancing drug delivery
MXPA06002648A (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades medidas por cox-2.
AU2003290031A1 (en) Method of improvement of blood circulation
WO2001091766A3 (en) Compositions for treating hand and wrist discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
WO2001091771A3 (en) Compositions for treating back and leg discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
DK1497250T3 (da) Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse
JP2017043593A (ja) 黒ニンニク及びビタミンｂ１を含有する組成物
NZ512402A (en) Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale
TH87926A (th) โภชนาการสำหรับผู้ป่วยอ้วนเกิน
LT2001072A (lt) Maisto papildas